drugset / Trial / NCT02288312
Food Effect and Dosage Form Proportionality Study of Eslicarbazepine Acetate
RandomizedCrossoverOpen-labelTreatment
Summary
Single-centre, open-label, randomised, gender-balanced, 3-way crossover, 3-period, 3-sequence study in 18 healthy male and female subjects.
Timeline
- Start
- 2007-05
- Primary completion
- 2007-07
- Completion
- 2007-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Eslicarbazepine acetate | Unknown | 400 mg | Oral |
| Subject | Eslicarbazepine acetate | Unknown | 800 mg | Oral |